남성용 체외 카테터 시장 : 유형, 용도, 지역별(2026-2034년)

The global male external catheters market size reached USD 2.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.5 Billion by 2034, exhibiting a growth rate (CAGR) of 6.20% during 2026-2034. The growing geriatric population across the globe, continual advancements in medical technology and the introduction of male external catheters with additional features, such as anti-leak mechanisms and improved adhesion, are key factors driving the market.

Male external catheters are medical devices designed to manage urinary incontinence in men. It is a non-invasive alternative to traditional indwelling catheters requiring insertion into the urethra. It consists of a sheath made of soft, flexible material, such as silicone or latex, placed over the penis. The sheath has an adhesive lining that helps it adhere securely to the skin, forming a leak-resistant seal. At the end of the sheath, a drainage tube connects to a collection bag, which collects the urine. One of the primary advantages of male external catheters is their convenience and ease of use. They can be applied without medical professionals and do not require any insertion into the body. This makes them a preferred option for individuals wishing to manage urinary incontinence at home or those with limited mobility. Using male external catheters also reduces the risk of urinary tract infections (UTIs) when compared to indwelling catheters. Since the device does not enter the urethra, the likelihood of introducing bacteria into the urinary tract is significantly lower. They are available in various sizes and styles to accommodate different individuals and preferences. Some may have features, such as anti-twist valves or non-slip adhesives, to enhance their performance.

MALE EXTERNAL CATHETERS MARKET TRENDS:

The male external catheters market has witnessed significant growth globally, driven by several factors contributing to their increasing adoption. These factors can be attributed to both demographic trends and continual advancements in medical technology. The aging population is one of the primary drivers of the market. As the global population ages, the prevalence of urinary incontinence in older men is rising. Male external catheters offer a practical solution for managing incontinence, allowing individuals to maintain their independence and quality of life. As a result, the growing elderly population, particularly in developed countries, has created a substantial market demand for these devices. In addition, manufacturers have introduced innovative designs and materials to improve the functionality and comfort of these devices. Developing softer, more flexible materials has enhanced the user experience, thereby reducing skin irritation and discomfort. Additionally, the introduction of male external catheters with additional features, such as anti-leak mechanisms and improved adhesion, have made the catheters more reliable and leak-resistant, thus driving their adoption. Furthermore, the increasing awareness and acceptance of male external catheters among healthcare professionals and patients have contributed to the market growth.

KEY MARKET SEGMENTATION:

Type Insights:

• Disposable External Catheters
• Reusable External Catheters

Application Insights:

• Hospitals
• Home Care
• Others

Regional Insights:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for male external catheters. Some of the factors driving the North America male external catheters market included the growing geriatric population, the expanding medical expenditure, continual advancements in medical technology, etc.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global male external catheters market. Detailed profiles of all major companies have been provided. Some of the companies covered include B. Braun SE, Becton Dickinson and Company, BioDerm Inc., Coloplast Corp., Dileh Medical supplies co., Ltd., Hollister Incorporated, Ribbel International Ltd., Sterimed Group, Teleflex Incorporated, Vitality Medical Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Male External Catheters Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Disposable External Catheters
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Reusable External Catheters
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Application

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Home Care
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

• 9.1 Overview
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 B. Braun SE
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 SWOT Analysis
  • 13.3.2 Becton Dickinson and Company
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
    • 13.3.2.4 SWOT Analysis
  • 13.3.3 BioDerm Inc.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Coloplast Corp.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 Dileh Medical supplies co.,Ltd.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
  • 13.3.6 Hollister Incorporated
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 SWOT Analysis
  • 13.3.7 Ribbel International Ltd.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 Sterimed Group
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 Teleflex Incorporated
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
    • 13.3.9.4 SWOT Analysis
  • 13.3.10 Vitality Medical Inc
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio